cprx stock price forecast

CPRX Stock Analysis Overview. According to 11 analysts the average rating for CPRX stock is Buy The 12-month stock price forecast is 1117 which is an increase of 3876 from the.

Zacks Analysts Anticipate Catalyst Pharmaceuticals Inc Nasdaq Cprx Will Announce Earnings Of 0 14 Per Share Defense World

Get Our PREMIUM Forecast Now from ONLY 849.

. Catalyst Pharmaceuticals Stock Prediction. Catalyst Pharm Inc CPRX gets an Overall Rank of 75 which is an above average rank under InvestorsObservers stock ranking. Catalyst Pharmaceuticals Inc Stock Forecast CPRX Stock Predictons by days.

Find the latest Catalyst Pharmaceuticals Inc. Catalyst Pharmaceuticals Inc. This is 412 less than the trading day before Thursday 5th May 2022.

4 analysts have issued 1 year target prices for Catalyst Pharmaceuticals stock. According to the issued ratings of 4 analysts in the last year the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. CPRX stock quote history news and other vital information to help you with your stock trading and investing.

Find the latest analyst research for Catalyst Pharmaceuticals Inc. Analyst estimates including CPRX earnings per share estimates and analyst recommendations. ---March 9 2022 356 PM EST.

For Catalyst Pharmaceuticals stock forecast for 2022 8 predictions are offered for each month of 2022 with average Catalyst Pharmaceuticals stock forecast of 814 a high forecast of 83. The stock is rated. On average they expect Catalyst Pharmaceuticals.

The Catalyst Pharmaceuticals stock price gained 202 on the last trading day Friday 20th May 2022 rising from 692 to 706. About the Catalyst Pharmaceuticals Inc. And has now gained 3 days in a rowIt will.

Close price at the end of the last trading day Friday 6th May 2022 of the CPRX stock was 722. Todays 52-Week Highs. Common Stock CPRX.

Based on analysts offering 12 month price targets. Provides Revenue Guidance for the Year 2022. As of 2022 May 26 Thursday current price of CPRX stock is 6890 and our data indicates that the asset price has.

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low. The average CATALYST PHARMACEUTICALS stock price prediction forecasts a potential upside of 6885 from the current CPRX share price of 687. US Markets Close In 3 min.

CPRX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Stock Market News - Financial News - MarketWatch. Their forecasts range from 875 to 1200.

Catalyst Pharmaceuticals Inc. - Try Now Risk-Free - Money-back guarantee. 5 analysts have assigned their ratings of the stocks forecast evaluation on a scale of 100-500 to indicate a strong buy to a strong sell recommendation.

Find the latest Catalyst Pharmaceuticals Inc. Meanwhile note that the median CPRX forecast price target median being the middle where half of analysts had a higher CPRX forecast and half had a lower CPRX forecast which is a. Find the latest Catalyst Pharmaceuticals Inc CPRX stock price forecast 12-month price target predictions and analyst recommendations.

Continued to forecast full year 2022 total revenues to be in the. Real time Catalyst Pharmaceuticals CPRX stock price quote stock graph news analysis. What is CPRXs Earnings Per Share.

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low.

Catalyst Pharmaceuticals Cprx Stock Price News Info The Motley Fool

Here S Why We Think Catalyst Pharmaceuticals Nasdaq Cprx Is Well Worth Watching Nasdaq

Catalyst Pharmaceuticals Stock Forecast Up To 8 044 Usd Cprx Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis